论文部分内容阅读
目的分析达美康与二甲双胍对2型糖尿病临床治疗效果及生活质量的影响。方法选取2014年7月至2016年7月70例2型糖尿病患者的临床资料,将其分为对照组和观察组,每组35例。前者予以二甲双胍治疗,后者在前者基础联用达美康治疗,观察比较两组血糖、血脂水平及生活质量情况。结果治疗后两组血糖、血脂水平均较治疗前下降,但对照组空腹血糖(FPG)、餐后2 h血糖(2 h PPG)、总胆固醇(TC)、三酰甘油(TG)、糖化血红蛋白(Hb A1c)指标均低于对照组(P<0.05);观察组生理机能、社会功能、精神状态、物质生活评分均高于对照组(P<0.05)。结论达美康结合二甲双胍治疗2型糖尿病可有效降低患者血糖、血脂水平,促进其生活质量提高,具有医疗推广价值。
Objective To analyze the effect of meticillin and metformin on the clinical efficacy and quality of life of type 2 diabetic patients. Methods Clinical data of 70 patients with type 2 diabetes from July 2014 to July 2016 were selected and divided into control group and observation group with 35 cases in each group. The former was treated with metformin, the latter combined with the former based on the United States Meikang treatment, observed and compared two groups of blood glucose, blood lipid levels and quality of life. Results After treatment, the levels of blood glucose and blood lipid decreased in both groups before and after treatment. However, fasting blood glucose (FPG), 2 h PPG, TC, TG, (Hb A1c) in the observation group were lower than those in the control group (P <0.05). The physical function, social function, mental status and physical life score of the observation group were higher than those of the control group (P <0.05). Conclusion Combination of meticillin and metformin in the treatment of type 2 diabetes patients can effectively reduce blood glucose and blood lipid levels and improve their quality of life, with the value of medical promotion.